Our platform is built on a proprietary database across sources including equity research, publications, SEC, FDA, clinical trials, and the latest news. Argon AI outputs thorough and complete insights across topics including therapeutic areas, indications, interventions, and companies.
Book a call to learn more. Top Life Science consulting firms and pharma companies use us today to automate their grunt work and free teams to focus on high-value strategy and execution.
Tedious and repetitive workflows: generating key insights for drug development is a highly manual and repetitive task that requires searching across a highly fragmented number of sources, summarizing information, formatting tables/charts, and a number of other tasks. Keeping the output of these workflows up-to-date requires manual data screening and updating.
Existing workflows are not keeping up with demand: at the same time, the amount of healthcare data, the number of drug development programs, and biological complexity is growing exponentially. This only exacerbates the problem, leading to a rise in prices and lower quality and speed.
We automate the grunt work to free up professionals to focus on strategy and execution! Argon is an AI-first platform that automates the process of aggregating, synthesizing, and generating insights to save teams time and money.
Our products allow teams to quickly find all relevant clinical trials, companies, and therapies for their research. Customers today use Argon for indication selection, competitive intelligence, clinical intelligence, and more.
→ Quickly find relevant clinical trials
→ Or ask a quick question about pharma-specific topics and get answers that outperform general LLMs or search engines.
→ You can easily save the relevant data you find into your Notebook for further analysis and collaboration with teammates!
Book a call with us today to automate your grunt work and free your teams to focus on strategy and execution.
Our team has experienced the insights problem and current solutions firsthand. We are bringing our diverse backgrounds across biopharma, ML research, and engineering together to dramatically reduce the cost and barriers of bringing life-saving therapies to market.